5[1]Lewis JF, Jobe AN. Surfactant and the adult respiratory distress syndrome[J]. Am Rev Respir Dis, 1993; 147:218～233
6[2]Taeusch HW. Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy[J]. Biol Neonate, 2000;77(suppl 1) :2～8
7[3]Creuwels LA, Van Golde LM, Haagsman HP. The pulmonary sur factant system: biochemical and clinical aspects [J]. Lung, 1997;175:1～39
8[4]Vadas P, Stefanski E, Wloch M, et al . Seeretory non-pancreatic phospholipase A2 and cyclooxygenase-2 expression by tracheobrone [J]. Eur J Biochem, 1996; 235:557～563
9[5]Hidi R, Vial D, Havet N, et al . Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophage[J]. Biochim pharmacol, 1997; 54(9): 1055～1058
10[6]Doyle IR, Bersten AD, Nicholas TE, et al . Surfactant protein-A and-B are elevated in plasma of patients with acute respiratory failure [J]. Am J Respir Crit Care Med, 1997; 156(4 pt 1) : 1217～1229
5Lu KW, William Taeusch H, Robertson B, et al. Polymer - surfactant treatment of meconium - induced acute lung injury [ J ]. Am J Respir Crit Care Med, 2000, 162 (2 Pt 1) : 623.
6Oh MH, Bae CW. Inhibitory effect of meconium on pulmonary surfaetant function tested in vitro using the stable microbubble test [J]. Eur J Pediat, 2000, 159 (10): 770.
7Cleary OM, Antunes MI, Ciesielka DA, et al. Exudative lung injury is associated with decreased levels of surfactant proteins in a rat model of meconium aspiration [J]. Pediatrics, 1997, 100 (6) : 998.
8Schrama A J, de Beaufort AJ, Sukul YR, et al. Phospholipase A2 is present in meconium and inhibit activity of pulmonary surfactant : an in vitro study [J]. Acta Paediatr, 2001, 90 (4): 412.
9Khammash H, Perlman M, Wojtulewicz J, et al. Surfactant therapy in full - term neonates with severe respiratory failure [ J ]. Pediatrics, 1993, 92:135.
